EPOCH starting dose level (level 1)
| Drug . | Dose . | Route . | Treatment days . |
|---|---|---|---|
| Infused agents* | |||
| Etoposide | 50 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Doxorubicin | 10 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Vincristine† | 0.4 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Bolus agents | |||
| Cyclophosphamide | 750 mg/m2/day | IV | 5 |
| Prednisone | 60 mg/m2/bid | Oral | 1, 2, 3, 4, 5 |
| G-CSF | 5 μg/kg/day | SC | 6 to ANC > 5 × 109/L past nadir |
| Next cycle‡ | Day 21 |
| Drug . | Dose . | Route . | Treatment days . |
|---|---|---|---|
| Infused agents* | |||
| Etoposide | 50 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Doxorubicin | 10 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Vincristine† | 0.4 mg/m2/day | CIV | 1, 2, 3, 4 (96 hours) |
| Bolus agents | |||
| Cyclophosphamide | 750 mg/m2/day | IV | 5 |
| Prednisone | 60 mg/m2/bid | Oral | 1, 2, 3, 4, 5 |
| G-CSF | 5 μg/kg/day | SC | 6 to ANC > 5 × 109/L past nadir |
| Next cycle‡ | Day 21 |